Arch Biopartners Inc.

TSXV Exchange | Jan 21, 2020, 1:22 PM EST | Real-time price

ARCH $ 0.94 RT
0.00 (0.00%)
Day Low: N/A
Day High: N/A
Detailed Quote
Open: N/A
High: N/A
Beta: 0.1252
Shares Out.: 59,412,302
Total Shares (All Classes)2: 59,412,302
Prev. Close: 0.94
Low: N/A
VWAP: 0.9317
Escrow Shares: 0
Market Cap (All Classes)2*: 55,847,564
Dividend: N/A
Div. Frequency: N/A
P/E Ratio: N/A
Listed Shares Out.1: 59,412,302
EPS: -0.04
Yield: N/A
Ex-Div Date: N/A
P/B Ratio: -23.50
Market Cap1: 55,847,564
Exchange: TSXV

(1) Number based only on listed classes of shares.

(2) Number sourced from third party data provider. For the most up to date information, please refer to the company's financial documents.

*Market Capitalization is based on Total Shares Outstanding for all share classes for the company. Convertible bonds and employee stock options that would otherwise be included in the Diluted Shares amount included in a company's filings/financials are not included.


Arch Biopartners Inc. is a clinical stage company focused on the development of innovative technologies that have the potential to make a significant medical or commercial impact. Arch is developing a drug platform to produce new drug candidates that inhibit organ inflammation caused via the DPEP-1 pathway. Continuing under development in the Arch portfolio is AB569, a potential new treatment for antibiotic resistant bacterial infections in the lungs or wounds; and, 'Borg' peptide coatings that ... More

Info TSX Venture

A comprehensive database of information on TSX Venture issuers

Show all links
Last 25 Trades
Copyright © QuoteMedia. Data delayed 15 minutes unless otherwise indicated. View delay times for all exchanges. Market Data powered by QuoteMedia, Fundamentals by Morningstar. See the QuoteMedia Terms of Use.